|
GLSI
|
Greenwich LifeSciences, Inc.
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
US
|
NASDAQ
|
|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PBYI
|
Puma Biotechnology Inc
|
US
|
NASDAQ
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ZYME
|
Zymeworks Inc.
|
US
|
NASDAQ
|
|
BAVA
|
Bavarian Nordic
|
DK
|
CO
|
|
GLENMARK
|
GLENMARK PHARMACEUTICALS LTD.
|
IN
|
BSE
|
|
RDPTF
|
Radiopharm Theranostics Limited
|
US
|
US
|
|
OSTX
|
OS Therapies Incorporated
|
US
|
US
|
|
08HH
|
SHANG.FOS.PHARM.GR.H YC 1
|
DE
|
F
|
|
3NK
|
ALPHAMAB ONCOLO.DL-000002
|
DE
|
F
|
|
83B
|
3SBio Inc
|
DE
|
F
|
|
9W8
|
IKONISYS EO 2
|
DE
|
F
|
|
D4S
|
Daiichi Sankyo Company Limited
|
DE
|
F
|
|
M55
|
MacroGenics Inc
|
DE
|
F
|
|
PQ6
|
Starpharma Holdings Limited
|
DE
|
F
|